Luecke, S.; Fottner, C.; Lahner, H.; Jann, H.; Zolnowski, D.; Quietzsch, D.; Grabowski, P.; Cremer, B.; Maasberg, S.; Pape, U.-F.;
et al. Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice. Cancers 2022, 14, 2718.
https://doi.org/10.3390/cancers14112718
AMA Style
Luecke S, Fottner C, Lahner H, Jann H, Zolnowski D, Quietzsch D, Grabowski P, Cremer B, Maasberg S, Pape U-F,
et al. Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice. Cancers. 2022; 14(11):2718.
https://doi.org/10.3390/cancers14112718
Chicago/Turabian Style
Luecke, Simone, Christian Fottner, Harald Lahner, Henning Jann, Dominik Zolnowski, Detlef Quietzsch, Patricia Grabowski, Birgit Cremer, Sebastian Maasberg, Ulrich-Frank Pape,
and et al. 2022. "Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice" Cancers 14, no. 11: 2718.
https://doi.org/10.3390/cancers14112718
APA Style
Luecke, S., Fottner, C., Lahner, H., Jann, H., Zolnowski, D., Quietzsch, D., Grabowski, P., Cremer, B., Maasberg, S., Pape, U.-F., Mueller, H.-H., Gress, T. M., Rinke, A., & the members of the German NET Registry.
(2022). Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice. Cancers, 14(11), 2718.
https://doi.org/10.3390/cancers14112718